Is KMC Speciality overvalued or undervalued?

As of 9 October 2025, KMC Speciality's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently considered undervalued. Key ratios include a PE ratio of 50.80, an EV to EBITDA of 21.05, and a ROCE of 15.52%.
In comparison to its peers, KMC Speciality's PE ratio is significantly lower than that of Max Healthcare at 93.04 and Apollo Hospitals at 70.37, both of which are categorized as very expensive. This suggests that KMC Speciality may offer a more favorable investment opportunity relative to its peers. Despite a recent decline in stock performance over the past year, the company's strong long-term returns, particularly a 250.36% increase over five years, highlight its potential for growth.